Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy

被引:32
|
作者
Rombouts, Eva K. [1 ]
Rosendaal, Frits R. [1 ,2 ]
van der Meer, Felix J. M. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Thrombosis & Haemostasis, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands
关键词
anticoagulation; vitamin K; vitamin K antagonists; diet; international normalized ratio; ATRIAL-FIBRILLATION; RISK-FACTORS; WARFARIN; VKORC1; OVERANTICOAGULATION; VARIABILITY; CYP2C9; SUPPLEMENTATION; ACENOCOUMAROL; MANAGEMENT;
D O I
10.1111/j.1365-2141.2010.08108.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>It is unclear what advice should be given to patients using vitamin K antagonists with respect to dietary vitamin K intake. We performed a nested case-control study in patients attending a Dutch anticoagulation clinic, to determine the association between vitamin K intake and subtherapeutic International Normalized Ratio (INR) values and the interaction between usual and recent vitamin K intake. Compared to patients with a normal usual vitamin K intake, those with a high vitamin K intake had a decreased risk of a subtherapeutic INR [Hazard Ratio (HR) 0 center dot 80, 95% confidence interval (CI): 0 center dot 56-1 center dot 16] and patients with a low vitamin K intake an increased risk (HR 1 center dot 33, 95% CI: 0 center dot 79-2 center dot 25). In patients with a low usual vitamin K intake, recent vitamin K intake was twice as high in cases as in controls (164 vs. 85 mu g/d). Such a difference was not observed in patients with a normal or high usual vitamin K intake. Our results suggest that a high vitamin K intake reduces the risk of a low INR by lessening the influence of incidental consumption of vitamin K rich food on the INR. These findings support the recommendation for patients on vitamin K antagonists to eat a sufficient amount of vitamin-K containing foods.
引用
收藏
页码:598 / 605
页数:8
相关论文
共 50 条
  • [31] Warfarin and vitamin K intake in the era of pharmacogenetics
    Lurie, Yael
    Loebstein, Ronen
    Kurnik, Daniel
    Almog, Shlomo
    Halkin, Hillel
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (02) : 164 - 170
  • [32] Dietary interactions and INR variability: retrospective evaluation of patients couples on oral anticoagulant therapy
    Sottilotta, G.
    Romeo, E.
    Consonni, D.
    Siboni, S. M.
    Latella, C.
    Oriana, V.
    Lombardo, V. Trapani
    MINERVA MEDICA, 2011, 102 (04) : 271 - 275
  • [33] Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?
    Steib, A.
    Barre, J.
    Mertes, M.
    Morel, M. H.
    Nathan, N.
    Ozier, Y.
    Treger, M.
    Samama, C. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (03) : 499 - 503
  • [34] Safety and Efficacy of Non-Vitamin K Oral Anticoagulant Use Early After Cardiac Surgery: A Systematic Review
    Wang, Erica H. Z.
    Ye, Jian
    Turgeon, Ricky
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (12) : 1525 - 1535
  • [35] Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation
    Sconce, E
    Khan, T
    Mason, J
    Noble, F
    Wynne, H
    Kamali, F
    THROMBOSIS AND HAEMOSTASIS, 2005, 93 (05) : 872 - 875
  • [36] Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature
    Dentali, Francesco
    Crowther, Mark
    Galli, Matteo
    Pomero, Fulvio
    Garcia, David
    Clark, Nathan
    Spadafora, Laura
    Witt, Daniel M.
    Ageno, Walter
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (06) : 671 - 681
  • [37] Worldwide management of oral anticoagulant therapy: the ISAM study
    Pengo, V
    Pegoraro, C
    Cucchini, U
    Iliceto, S
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2006, 21 (01) : 73 - 77
  • [38] Worldwide Management of Oral Anticoagulant Therapy: the ISAM Study
    Vittorio Pengo
    Cinzia Pegoraro
    Umberto Cucchini
    Sabino Iliceto
    Journal of Thrombosis and Thrombolysis, 2006, 21 : 73 - 77
  • [39] Current challenges and future prospects in oral anticoagulant therapy
    Czuprynska, Julia
    Patel, Jignesh P.
    Arya, Roopen
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (06) : 838 - 851
  • [40] Warfarin control in patients transitioning to warfarin after non-vitamin K oral anticoagulant (NOAC) therapy
    Nijole Bernaitis
    Tony Badrick
    Andrew K. Davey
    Julia Crilly
    Shailendra Anoopkumar-Dukie
    Journal of Thrombosis and Thrombolysis, 2018, 46 : 461 - 465